Acesion Pharma
Latest round
- Series B
Last raised
- Sep 2023
Total raised
- $48M
Investors
- 4
About Acesion Pharma
Founded in 2011, Acesion Pharma ApS is engaged in the development of therapies targeting atrial fibrillation (AF). The company is headquartered in Copenhagen, Denmark.Acesion Pharma ApS focuses on developing treatments for atrial fibrillation (AF), particularly through its lead compound AP30663, which targets the SK ion channel. This first-in-class drug aims to provide a novel mechanism for addressing AF, a condition affecting millions globally.Acesion Pharma ApS reported zero revenue for the year 2021.90.
Who invested in Acesion Pharma
4 investors across 1 round
See all investors in Acesion Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Sep 26, 2023
Amount
$48M
Investors
Questions about Acesion Pharma
Who invested in Acesion Pharma?
Acesion Pharma has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Acesion Pharma raised?
Acesion Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Acesion Pharma last raise money?
Acesion Pharma's most recent round on record is a Series B, in Sep 2023.
What does Acesion Pharma do?
Founded in 2011, Acesion Pharma ApS is engaged in the development of therapies targeting atrial fibrillation (AF).
Where is Acesion Pharma headquartered?
Acesion Pharma is headquartered in Copenhagen, Denmark.
Which VCs invest in companies like Acesion Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Acesion Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Acesion Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.